We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Novel Imaging Technique Visualizes Potential Cancer Treatments in Action

By MedImaging International staff writers
Posted on 20 Apr 2015
Print article
Image: A new imaging techniques to see how brain cancer cells (the darker gray on the bottom of the large image above) take in gold nanorod treatment (the small gray specks). The four magnified images on the right show how the cell takes up the treatment across a span of 30 seconds (Photo courtesy of VirginiaTech).
Image: A new imaging techniques to see how brain cancer cells (the darker gray on the bottom of the large image above) take in gold nanorod treatment (the small gray specks). The four magnified images on the right show how the cell takes up the treatment across a span of 30 seconds (Photo courtesy of VirginiaTech).
A new and innovative imaging technique for observing cancer treatments in brain tumor cells has been developed by researchers at the Virginia Tech Carilion Research Institute (Roanoke, VA, USA).

The study was published in the March 3, 2015, online edition of the journal NANO Letters. The researchers used nanotechnology to target glioblastoma tumor stem cells which tend to survive existing cancer treatments and grow into new tumors.

The researchers isolated glioblastoma tumor stem cells in cultures, treated them with gold nanorod cancer therapy, and observed the results at the cellular level using in situ transmission electron microscopy.

"Zhi Sheng, assistant professor at Virginia Tech Carilion Research institute, said, "We've never been able to directly observe the actions of potential cancer treatments this way before. We can look at single-cell delivery of cancer treatments, and see how the individual cells respond. If we can learn how to kill these cells, we should be able to improve our chances of developing effective treatments by being able to directly observe the effects of the possible therapeutics."

Related Links:

The Virginia Tech Carilion Research Institute


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Ultrasound Software
UltraExtend NX
Ultrasound Doppler System
Doppler BT-200
New
X-Ray QA Meter
Piranha CT

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.